These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 13683915

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A comparison of the in vivo inhibition of brain and liver monoamine oxidase as produced by beta-phenylisopropylhydrazine (PIH) and iproniazid.
    GOGERTY JH, HORITA A.
    J Pharmacol Exp Ther; 1960 Aug; 129():357-60. PubMed ID: 13850477
    [No Abstract] [Full Text] [Related]

  • 4. The effect of monoamine oxidase inhibitors and tryptophan on the tryptamine content of animal tissues and urine.
    HESS SM, REDFIELD BG, UDENFRIEND S.
    J Pharmacol Exp Ther; 1959 Nov; 127():178-81. PubMed ID: 14401504
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [On the adrenergic action of iproniazid, inhibitor of monoamine oxidase].
    MEYER F.
    C R Hebd Seances Acad Sci; 1961 Apr 24; 252():2616-8. PubMed ID: 13769974
    [No Abstract] [Full Text] [Related]

  • 7. Influence of monoamine oxidase inhibitors on 5-hydroxytryptamine synthesis in the brain.
    Weber LJ.
    Proc Soc Exp Biol Med; 1966 Oct 24; 123(1):35-8. PubMed ID: 4380811
    [No Abstract] [Full Text] [Related]

  • 8. Physiological significance of monoamine oxidase.
    IMAIZUMI R, OMORI K, UNOKI A, SANO K, WATARI Y, NAMBA J, INUI K.
    Jpn J Pharmacol; 1959 Mar 24; 8():87-95. PubMed ID: 13852733
    [No Abstract] [Full Text] [Related]

  • 9. Influence of iproniazid and 5-hydroxytryptophan on the 5-hydroxytryptamine content in the gastro-intestinal tract and thyroid gland of rats.
    PAASONEN MK, KARKI NT, MOLKKA S.
    Ann Med Exp Biol Fenn; 1961 Mar 24; 39():405-10. PubMed ID: 14482989
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The distribution of monoamine oxidase and succinic oxidase in brain.
    WEINER N.
    Proj Rep USAF Sch Aviat Med; 1960 Jun 24; 60(65):1-7. PubMed ID: 24545966
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Biochemical and pharmacological effects of the monoamine oxidase inhibitors, iproniazid, 1-phenyl-2-hydrazinopropane (JB 516) and 1-phenyl-3-hydrazinobutane (JB 835).
    SPECTOR S, SHORE PA, BRODIE BB.
    J Pharmacol Exp Ther; 1960 Jan 24; 128():15-21. PubMed ID: 13833205
    [No Abstract] [Full Text] [Related]

  • 18. Activity of monoamine oxidase in relation to the 5-hydroxytrypatamine and norepinephrine content of the rat brain.
    GEY KF, PLETSCHER A.
    J Neurochem; 1961 Feb 24; 6():239-43. PubMed ID: 13704855
    [No Abstract] [Full Text] [Related]

  • 19. Post mortem increase of 5-hydroxytryptamine in rat brain after 5-hydroxytryptophan administration.
    GEY KF, PLETSCHER A.
    Experientia; 1960 Aug 15; 16():372-3. PubMed ID: 13704859
    [No Abstract] [Full Text] [Related]

  • 20. [Apropos of iproniazid. Inhibition of monoamine oxidase in therapy].
    HOLZER J, SOLIGNAC H.
    Prod Pharm; 1961 Oct 15; 16():482-4. PubMed ID: 13908637
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.